David Shapiro
CIK 1559570 · Chief Medical Officer · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
82
Lifetime Open-Market Net
-$32.90M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DSGN | Director | — | $10.97 | — | $0 | 2 | 2026-06-11 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | — | $28.69 | — | $0 | 4 | 2025-06-20 |
| VivoSim Labs, INC. (ONVO) Delisted | Director | — | $2.04 | — | $0 | 2 | 2019-09-09 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Chief Medical Officer | 41,499 | $19.00 | $788.5K | -$32.90M | 74 | 2019-05-03 |
Recent Filings · Page 9 of 9
82 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-04-11 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Mixed | +5,064 | -$195.5K | EDGAR |
| 2012-11-20 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 81–82 of 82
Prev
Page 9 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.